Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Inari Medical
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical signs and symptoms consistent with acute PE
Echo, CTPA or pulmonary angiographic evidence of proximal filling defect in at least one main or lobar pulmonary artery
Scheduled for PE treatment with the FlowTriever System per the Investigator's discretion\*
You may not be if
Unable to be anticoagulated with heparin or alternative
Diagnosis with a minor PE with a less than 0.9 RV/LV ratio
Known sensitivity to radiographic contrast agents that, in the Investigator's opinion, cannot be adequately pre-treated\*
Imaging evidence or other evidence that suggests, in the Investigator's opinion, the subject is not appropriate for mechanical thrombectomy intervention\*
Life expectancy \< 30 days, as determined by Investigator
Current participation in another investigational drug or device treatment study that, in the Investigator's opinion, would interfere with participation in this study
Clareo Health | FlowTriever All-Comer Registry for Patient Safety and Hemodynamics
